Medical Condition News

RSS

Women with high levels of homocysteine more likely to suffer from Alzheimer's disease

Middle-aged women with high levels of a specific amino acid in their blood are twice as likely to suffer from Alzheimer's many years later, reveals a thesis from the Sahlgrenska Academy at the University of Gothenburg, Sweden. This discovery this could lead to a new and simple way of determining who is at risk long before there are any signs of the illness.

6 Nov 2009

Asthma associated with both genetics and environmental exposures

While progress has been made in identifying genes associated with asthma, the disease is complex, and its development is likely dependent upon both genetics and environmental exposures, according to a leading expert presenting at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Miami Beach, Fla.

6 Nov 2009

Positive interim data from the multicenter randomized Phase II trial of palifosfamide presented

ZIOPHARM Oncology, Inc. presented today at the 15th Annual Connective Tissue Oncology Society (CTOS) Meeting, positive interim data from the multicenter randomized Phase II trial of palifosfamide (ZymafosTM, ZIO-201) treating patients with unresectable or metastatic soft tissue sarcoma.

6 Nov 2009

One in three asthma patients are hospitalized, reveals new national survey

In the past year, an estimated more than one million patients were hospitalized and nearly three million visited emergency rooms in the United States as a result of asthma, according to a new comprehensive national survey.

6 Nov 2009

Data on Puredel's Ossulin to be presented at the San Francisco Diabetes Technology Meeting

The first public data on Ossulin™ a new oral insulin product, will be presented today at the 9th Annual Diabetes Technology Meeting in San Francisco, CA. Ossulin™ is being developed by Puredel Limited, a joint-venture between the European pharmaceutical specialty company CM&D Pharma Limited and Natreon Inc., New Brunswick, NJ., developers of the proprietary delivery platform.

6 Nov 2009

Health researchers speak about PTSD in light of Remembrance Day

They've seen horrors, experienced constant threats and survived traumatic events. Canada's military personnel often come back home with memories they'd rather forget. It's not scientifically understood why some soldiers develop post-traumatic stress disorder (PTSD) while others don't. However, many veterans simply don't ask for psychological help.

6 Nov 2009

Research reveals new biological function of polycystins in regulating pressure sensing

What is the role of proteins called polycystins in patients with polycystic kidney disease? A team of researchers from CNRS and INSERM, led by Eric Honoré from the Institut de Pharmacologie Moléculaire et Cellulaire (IPMC, Université de Nice Sophia Antipolis/CNRS) has elucidated the molecular and cellular mechanisms linked to polycystin malfunctions that cause this common hereditary disease.

6 Nov 2009

cbm's initiative to help families break the cycle of poverty and disability

How can the gift of a goat this holiday season transform the life of a child in Africa?

6 Nov 2009

Landmark meeting discusses goal of detecting Alzheimer disease before symptoms appear

This past October, 214 researchers from the U.S., Europe, and Australia, as well as representatives of families with aggressive genetic forms of Alzheimer disease (AD), met at Washington University, St. Louis, Missouri, to devote two intense days of talks and discussion to their goal of detecting this disease before symptoms appear. By a growing consensus, defining the "silent" phase of AD has become the field's central challenge if it is to modernize drug testing and lay the groundwork for AD prevention trials.

6 Nov 2009

Incontinence has a significant impact on caregiver's life

Incontinence in a parent, grandparent or spouse has a significant emotional impact on a caregiver's life, according to a survey released today by Caring.com and SCA, the makers of TENA® (www.tena.us).

6 Nov 2009

Free electronic TBI screenings for veterans

With Veterans Day approaching on November 11, our thoughts turn to supporting our veterans. Hospital for Special Care (HSC) is offering screenings for the effects of Traumatic Brain Injury (TBI) in veterans returning from service in Iraq and Afghanistan. HSC is an extensive resource to veterans and their families on the education and treatment of TBI.

6 Nov 2009

Dentists can play a live-saving role by identifying patients at risk of fatal heart attacks: Study

A new study indicates dentists can play a potentially life-saving role in health care by identifying patients at risk of fatal heart attacks and referring them to physicians for further evaluation.

6 Nov 2009

Results of LightTouch Non-invasive Cervical Cancer Detection Device trial presented

Results of the FDA pivotal clinical trial for the LightTouch™ Non-invasive Cervical Cancer Detection Device conducted by Guided Therapeutics, Inc. (GT), indicated that the current system for diagnosing cervical disease missed the same amount of disease as a landmark study carried out by the National Cancer Institute (NCI).

6 Nov 2009

CPEX Pharmaceuticals to feature Nasulin at the Diabetes Technology Meeting

CPEX Pharmaceuticals, Inc. today announced that its intranasal insulin product candidate, NasulinTM, will be featured in an oral presentation and four abstracts at the Ninth Annual Diabetes Technology Meeting, November 5-7, 2009 at the Hyatt Regency Airport in San Francisco, California.

6 Nov 2009

Gene therapy saves two children with adrenoleukodystrophy

The ELA association and Zinedine Zidane, its emblematic ambassador, are proud to announce a world premiere: the results regaring the gene therapy in adrenoleukodystrophy conducted in France have just been published in the prestigious journal Science. Two children have been treated and their diseases have been halted. The children are doing well, which is unexpected for a disease destroying the brain in a few months. This discovery opens up treatment perspectives for numerous widespread diseases.

6 Nov 2009

Physical education plays a key role for low-income communities in curbing obesity and improving fitness

School-based physical education plays a key role in curbing obesity and improving fitness among adolescents from low-income communities, according to a new study led by researchers at the University of California, San Francisco and UC Berkeley.

6 Nov 2009

Autism Consortium holds its fourth annual symposium to update on autism

The Autism Consortium, an innovative collaboration of researchers, clinicians, funders and families dedicated to catalyzing research and enhancing clinical care for autism spectrum disorders (ASDs), held its fourth annual symposium on October 28th, 2009, at Harvard Medical School in Boston.

6 Nov 2009

Boosting NAD+ after spinal cord injury may prevent permanent nerve death

Substances naturally produced by the human body may one day help prevent paralysis following a spinal cord injury, according to researchers at Weill Cornell Medical College. A recent $2.5 million grant from the New York State Spinal Cord Injury Research Board will fund their research investigating this possibility.

6 Nov 2009

TREANDA induces durable responses in indolent B-cell non-Hodgkin's lymphoma patients

Cephalon, Inc. today announced the journal Cancer has published a pivotal study demonstrating that TREANDA® (bendamustine HCl) for Injection induced durable responses in patients with indolent B-cell non-Hodgkin's lymphoma (NHL) whose disease had progressed during or within six months of treatment with rituximab.

6 Nov 2009

FDA grants orphan drug designation for Sunesis Pharmaceuticals' voreloxin

Sunesis Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted voreloxin orphan drug designation for the treatment of acute myeloid leukemia (AML). Sunesis is currently conducting two Phase 2 clinical trials of voreloxin in AML: a single-agent study, known as REVEAL-1, of voreloxin in newly diagnosed elderly AML patients unlikely to benefit from standard induction chemotherapy and a study evaluating voreloxin in combination with cytarabine in relapsed/refractory AML.

6 Nov 2009

Medical Condition News

Women with high levels of homocysteine more likely to suffer from Alzheimer's disease

Asthma associated with both genetics and environmental exposures

Positive interim data from the multicenter randomized Phase II trial of palifosfamide presented

One in three asthma patients are hospitalized, reveals new national survey

Data on Puredel's Ossulin to be presented at the San Francisco Diabetes Technology Meeting

Health researchers speak about PTSD in light of Remembrance Day

Research reveals new biological function of polycystins in regulating pressure sensing

cbm's initiative to help families break the cycle of poverty and disability

Landmark meeting discusses goal of detecting Alzheimer disease before symptoms appear

Incontinence has a significant impact on caregiver's life

Free electronic TBI screenings for veterans

Dentists can play a live-saving role by identifying patients at risk of fatal heart attacks: Study

Results of LightTouch Non-invasive Cervical Cancer Detection Device trial presented

CPEX Pharmaceuticals to feature Nasulin at the Diabetes Technology Meeting

Gene therapy saves two children with adrenoleukodystrophy

Physical education plays a key role for low-income communities in curbing obesity and improving fitness

Autism Consortium holds its fourth annual symposium to update on autism

Boosting NAD+ after spinal cord injury may prevent permanent nerve death

TREANDA induces durable responses in indolent B-cell non-Hodgkin's lymphoma patients

FDA grants orphan drug designation for Sunesis Pharmaceuticals' voreloxin

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News